Literature DB >> 1150347

Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line.

R Kiessling, G Petranyi, G Klein, H Wigzel.   

Abstract

Spleens of normal young mice of certain genotypes contain lymphocytes that can kill strain A-derived YAC-1 and some other in vitro-grown Moloney lymphoma lines in a 51Cr-release cytotoxic test. We have previously shown that mouse strains can be classified as high or low reactors in this test. F(1) hybrids between low- and high-reactive strains are high-reactive. In the present study, strain-A mice and eight different A F(1) hybrids were tested in parallel for their spleen-cell-mediated killing effect in vitro and their ability to reject graded numbers of YAC ascites or in vitro cultivated cells in vivo. There was a clear correlation between in vitro cytotoxicity and in vivo rejection in all tested genotypes. In segregating (A times C57Bl) times A backcross mice, in vivo rejection of YAC cells was H-2 linked. This is in line with the earlier backcross analysis of the in vitro cytotoxicity, suggesting a polygenic control with at least one H-2 linked factor.

Entities:  

Mesh:

Year:  1975        PMID: 1150347     DOI: 10.1002/ijc.2910150608

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  31 in total

1.  Impaired T cell function and decreased natural killer activity in patients with liver cirrhosis and their significance in the development of hepatocellular carcinoma.

Authors:  T Morizane; T Watanabe; K Tsuchimoto; M Tsuchiya
Journal:  Gastroenterol Jpn       Date:  1980

Review 2.  The role of natural killer cells in tumor control--effectors and regulators of adaptive immunity.

Authors:  Morgan E Wallace; Mark J Smyth
Journal:  Springer Semin Immunopathol       Date:  2005-02-24

Review 3.  Natural killer activity: early days, advances, and seminal observations.

Authors:  John R Ortaldo; Robert H Wiltrout; Craig W Reynolds
Journal:  Crit Rev Oncog       Date:  2014

4.  Genetic studies on natural resistance to Moloney lymphoma (YAC) isografts. II. Selective introduction of resistance genes, derived from C57BL/6 or CBA, to strain A/Sn background.

Authors:  L Ahrlund-Richter; C Nordstedt; G Klein; E Klein
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

5.  Enhancement of spontaneous killer cytotoxicity by soluble factor.

Authors:  F M Hofman; C A Spina
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

Review 6.  Natural killer cell receptors and their ligands in liver diseases.

Authors:  Satoshi Yamagiwa; Hiroteru Kamimura; Takafumi Ichida
Journal:  Med Mol Morphol       Date:  2009-03-18       Impact factor: 2.309

7.  Natural killer cell activity in inflammatory joint disease.

Authors:  R D Armstrong; G S Panayi
Journal:  Clin Rheumatol       Date:  1983-09       Impact factor: 2.980

8.  Depressed levels of granular lymphocytes with natural killer (NK) cell function in 247 cancer patients.

Authors:  C M Balch; A B Tilden; P A Dougherty; G A Cloud
Journal:  Ann Surg       Date:  1983-08       Impact factor: 12.969

Review 9.  Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution.

Authors:  G Klein; E Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

10.  Modulation of antitumoral antibody-dependent cellular cytotoxicity and natural killer activity by Adriamycin and daunorubicin.

Authors:  R W Pfeifer; H B Bosmann
Journal:  Agents Actions       Date:  1982-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.